Literature DB >> 3121415

Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1.

C Pukel1, H Baquerizo, A Rabinovitch.   

Abstract

An assay was developed to detect the cytotoxic effects of cytokines on rat pancreatic islet cells in monolayer culture. Cell lysis was detected by a 51Cr-release assay after 4 days of incubation with various cytokines. When tested alone, murine (rat and mouse) interferon-gamma (mIFN-gamma) produced a small dose-dependent lysis of islet cells; human IFN-gamma, mouse IFN-alpha/beta, interleukins 1 and 2 (IL-1 and IL-2), tumor necrosis factor (TNF), and lymphotoxin (LT) were inactive. When added together, the following combinations of cytokines showed synergistic cytotoxic effects: TNF (or LT) plus IL-1, TNF (or LT) plus mIFN-gamma, and IL-1 plus mIFN-gamma. These results indicate that the cytokine products of mononuclear cells of the immune system, IFN-gamma, TNF, LT, and IL-1 have strong synergistic cytotoxic effects on islet cells and therefore may act as direct chemical mediators of islet beta-cell destruction in type I (insulin-dependent) diabetes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3121415     DOI: 10.2337/diab.37.1.133

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  69 in total

Review 1.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

2.  The battered β-cell: usual suspects and guilt by association.

Authors:  R Paul Robertson
Journal:  J Clin Endocrinol Metab       Date:  2011-12       Impact factor: 5.958

3.  Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation.

Authors:  J H Hughes; J R Colca; R A Easom; J Turk; M L McDaniel
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

4.  Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1.

Authors:  C Southern; D Schulster; I C Green
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

Review 5.  Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators.

Authors:  Sarita Negi; Alissa K Rutman; Steven Paraskevas
Journal:  Curr Diab Rep       Date:  2019-07-31       Impact factor: 4.810

6.  Biomarkers for type 1 diabetes.

Authors:  Sharad Purohit; Jin-Xiong She
Journal:  Int J Clin Exp Med       Date:  2008-02-29

7.  Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice.

Authors:  I L Campbell; M V Hobbs; J Dockter; M B Oldstone; J Allison
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

8.  Pathogenicity of T helper 2 T-cell clones from T-cell receptor transgenic non-obese diabetic mice is determined by tumour necrosis factor-alpha.

Authors:  Jing He; Kathryn Haskins
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

9.  Abnormal TNF-alpha production in diabetes-prone BB rats: enhanced TNF-alpha expression and defective PGE2 feedback inhibition.

Authors:  H Rothe; C Ongören; S Martin; P Rösen; H Kolb
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

10.  Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats.

Authors:  U Zumsteg; J I Reimers; F Pociot; L Mørch; S Helqvist; M Brendel; R Alejandro; T Mandrup-Poulsen; C A Dinarello; J Nerup
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.